MacroGenics is pursuing alliances to participate in development of its proprietary product candidates and technology platforms.
Learn moreSince its founding in 2000, MacroGenics has applied its world-class antibody capabilities to create life-changing medicines. The company’s innovative product candidates leverage its fully-integrated capabilities and its multiple, proprietary technology platforms.
Learn more 2008 News Archive
September 26, 2008 | BioWorld Today
MacroGenics Raises $25M To Boost Stem Cell Line
September 26, 2008 | Washington Business Journal
New Venture Round Gives MacroGenics $25M Boost
September 25, 2008 | The Washington Post
Biotech Raises $25 Million In Financing
August 25, 2008 | BioWorld Today
86 Years After Insulin, Type I Diabetes Drugs Promise More
July 18, 2008 | The Washington Post
MacroGenics Buys Drug Developer To Bolster Cancer Work
July 17, 2008 | BioWorld Today
MacroGenics Boosts Anticancer Pipeline With Raven Acquisition
July 17, 2008 | Washington Business Journal
MacroGenics Buys California-Based Raven Biotechnologies
January 17, 2008 | Forbes
Delaying Diabetes
News Archive: 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | View All